The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current earnings are โน33.42 Billion. a decrease over its 2023 earnings that were of โน669.56 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | โน392.87 B | -41.32% |
2023 | โน669.56 B | 6.93% |
2022 | โน626.17 B | 9.63% |
2021 | โน571.19 B | -17.61% |
2020 | โน693.25 B | -11% |
2019 | โน778.92 B | -4.26% |
2018 | โน813.61 B | -0.54% |
2017 | โน818.04 B | 4.74% |
2016 | โน781.05 B | 14.85% |
2015 | โน680.04 B | 42.85% |
2014 | โน476.06 B | 6.08% |
2013 | โน448.78 B | 5.11% |
2012 | โน426.96 B | 20.7% |
2011 | โน353.74 B | -21.95% |
2010 | โน453.22 B | 2.17% |
2009 | โน443.58 B | -0.88% |
2008 | โน447.50 B | 32.54% |
2007 | โน337.63 B | -1.47% |
2006 | โน342.66 B | -17.42% |
2005 | โน414.94 B | 43.39% |
2004 | โน289.38 B | 7% |
2003 | โน270.45 B | -550.38% |
2002 | -โน60.06 Billion | -141.78% |
2001 | โน143.74 B | 0.72% |
2000 | โน142.71 B | 6.9% |
1999 | โน133.50 B | 27.92% |
1998 | โน104.36 B | 42.14% |
1997 | โน73.42 B | -10.49% |
1996 | โน82.02 B | 21.14% |
1995 | โน67.71 B | 34.99% |
1994 | โน50.16 B | -0.66% |
1993 | โน50.49 B | 5.22% |
1992 | โน47.99 B | 256.55% |
1991 | โน13.45 B | 549.79% |
1990 | โน2.07 B | -157.58% |
1989 | -โน3.6 Billion | -410.29% |
1988 | โน1.15 B | -20.47% |
1987 | โน1.45 B | 263.83% |
1986 | โน0.40 B | 487.5% |
1985 | โน68.19 M | -112.7% |
1984 | -โน0.54 Billion |